+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurorehabilitation Devices - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 463 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141284

Global Neurorehabilitation Devices Market to Reach US$2.1 Billion by the Year 2026


Neurorehabilitation devices are intended to improve function and wellbeing as well as alleviate symptoms of various nervous system disorders and trauma. Neurorehabilitation devices are used to examine the brain or central nervous system as well as deploy specific electric signals to fibers of spinal cord to recover limb movements. These devices encompass non-invasive brain stimulators, wearable devices, brain-computer interfaces and neuro-robotic systems. Intended to mitigate symptoms and improve neurological function, these devices are commonly used in physiotherapy and improve quality of life of patients. Growth in the global market is set to be fueled by high incidence of neurological conditions, rising geriatric population and technological advances. The market is anticipated to gain from increasing influx of new companies with innovative devices and better access to healthcare services. Neurorehabilitation devices are witnessing extensive use in clinical settings, cognitive care, healthcare centers and research institutes. The combination of rapidly advancing robotics technology and neuroscience is leading to the development and availability of next-generation rehabilitation techniques. The market expansion is also favored by consistent focus of companies on technological advances to come up with innovative devices capable of offering better therapeutic options for neurological conditions and improving patient outcomes.

Amid the COVID-19 crisis, the global market for Neurorehabilitation Devices estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$2.1 Billion by 2026, growing at a CAGR of 14.8% over the analysis period. Neurorobotic Systems, one of the segments analyzed in the report, is projected to grow at a 17.1% CAGR to reach US$1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Brain Computer Interface segment is readjusted to a revised 11.1% CAGR for the next 7-year period. This segment currently accounts for a 25% share of the global Neurorehabilitation Devices market. Neurorobotic devices refer to a new method that combines neuroscience, rehabilitation and robotics to treat neurological disorders, and the method used for treatment often depends on the specific function that needs to be restored. Currently, robotic intervention is gaining popularity with expanding applications of mobility restoration in patients with spine and neurological disorders, brain trauma, spinal injuries, cerebral palsy, and several other conditions. Neural interfaces or brain-machine interfaces represent a relatively new system for neurorehabilitation that is finding increased use in clinical applications. These systems facilitate communication between a patient`s brain and an external device.

The U.S. Market is Estimated at $433.7 Million in 2022, While China is Forecast to Reach $270.3 Million by 2026


The Neurorehabilitation Devices market in the U.S. is estimated at US$433.7 Million in the year 2022. The country currently accounts for a 38.5% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$270.3 Million in the year 2026 trailing a CAGR of 21.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 14.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR while Rest of European market (as defined in the study) will reach US$331.3 Million by the end of the analysis period. North America retains dominant position on account of rising cases of neurological disorders, increasing aging population and technological advancements. The market growth is facilitated by rising awareness about advantages of neurorehabilitation devices coupled with presence of a robust healthcare infrastructure. Europe is another key market and growth is attributable to rising cases of neurological disorders and availability of numerous approved devices. Growth in Asia-Pacific region is being driven by increasing incident of neurological disorders, rising geriatric population and strong demand for advanced neurorehabilitation devices.

Novel Multi-electrode Stimulation for Treatment of Spinal Cord Injuries in the Spotlight


Physiotherapists use a variety of tools, including electrotherapy, to manage pain, restore range of motion, and treat conditions of the musculoskeletal system. Using specialised devices designed to deliver customised levels of electrical stimulation to the body`s nerves, muscles, or tendons, physiotherapists seek to harness the power of electrotherapy to treat injuries, promote healing, and offer pain relief. Electrotherapy is a gentle and non-invasive modality that works by stimulating nerves and muscles through the surface of the skin. Electrical stimulation activates muscles in patients with spinal cord injuries, enabling them to move and function independently. Technological advancements in microelectronics, advent of feedback-based system design, biomimetic stimulation patterns, and device-based therapies are transforming the neuromodulation space. Recent advancements in noninvasive neuromodulation have led to emerging tools for treatment of chronic neuropathic pain. Treatment with neuromodulation devices involves minimally invasive surgery, and can help those suffering from chronic pain by significantly decreasing pain levels and improving their quality of life. Additionally, it may also decrease the use of chronic steroids and opioid pain medications. Current noninvasive stimulation techniques, such as transcranial magnetic stimulation (TMS) and transcranial current stimulation (TCS), have shown promising pain reduction effects. Low intensity transcranial focused ultrasound (tFUS) has emerged as a safe, noninvasive neuromodulation technique with high spatial resolution and focality with capability of accessing the deep brain. Neuromodulation techniques, using implantable or, especially, wearable devices to deliver certain controlled physical energy, holds great promise for revolutionizing the current practice for pain treatment.

Wearable Devices Segment to Reach $454.6 Million by 2026


The neurorehabilitation wearable devices segment is poised to maintain its positive trajectory due to availability of innovative options offering better alternatives to traditional neurorehabilitation approaches. Increasing cases of stroke in the US and other countries are poised to push uptake of wearable neurorehabilitation devices through all phases of the treatment process. In the global Wearable Devices segment, USA, Canada, Japan, China and Europe will drive the 15.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$166.6 Million will reach a projected size of US$455.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$28.6 Million by the year 2026, while Latin America will expand at a 17.9% CAGR through the analysis period.

Select Competitors (Total 95 Featured):

  • Abbott Laboratories
  • AlterG, Inc.
  • Biometrics Ltd.
  • Bioness Inc.
  • BIONIK Laboratories Corp.
  • Boston Scientific Corporation
  • Ectron Ltd
  • Ekso Bionics Holdings Inc.
  • Eodyne
  • Helius Medical Technologies
  • Hocoma AG
  • Instead Technologies Ltd.
  • Kinestica
  • Medtronic plc
  • Neofect
  • Neuro Rehab VR
  • Reha Technology AG
  • Rehab-Robotics Company Limited.
  • Rex Bionics Ltd
  • Saebo, Inc.
  • Tyromotion GmbH

What`s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the digital archives
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Neurological Disorders and Disability - A Prelude
  • Neurorehabilitation - A Sought-after Method for Rehabilitation Patients
  • Neurorehabilitation Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Neurorehabilitation Devices Market Experiences High Anxiety & Stress amid COVID-19
  • Global Market Prospects and Outlook
  • Neurorehabilitation Devices Market to Uphold Impressive Growth Rate Going Forward
  • Neurorehabilitation Remains Dynamic Domain with Progressive Advancements
  • Neuro-Robotic Devices & Stroke: Prime Segments of Neurorehabilitation Devices Market
  • North America Hold Majority Stake in Neurorehabilitation Devices Market
  • Immense Burden of Neurological Conditions in US Paves Way for Neurorehabilitation Devices
  • Market Restraints
  • Players Determined to Keep Neurorehabilitation Devices Market Vibrant with Innovations
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Neurological Conditions Drive Market Growth
  • Annual Incidence of Adult-Onset Neurologic Disorders in the US
  • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Increasing Adoption of Neurorobotic Systems
  • Exoskeleton Robots Add Sophistication in Neurorehabilitation
  • AI Augments Prosthetic Technology
  • Researchers Develop Neurorobotic Prosthetic Arm to Restore Natural Brain Behaviors
  • Select Robotic Devices
  • Robot-assisted Therapy Vs Other Therapies
  • Limitations
  • Technological Developments
  • Brain Stimulators Seek to Widen their Role in Neurorehabilitation
  • Global Alzheimer's Prevalence by Age Group: 2020
  • Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
  • Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
  • Select Available Deep Brain Stimulation Devices Available in the Market
  • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
  • Innovative Multi-Electrodes with Potential to Improve Spinal Cord Stimulation
  • Non-Invasive Brain Stimulation
  • Neurorehabilitation Wearable Devices Market Set to Deliver Stunning Performance
  • Novel Wristbands: A Primary Market Driver
  • Wearable Devices Set to Transform Traditional Approaches to Neurorehabilitation of Stroke Patients
  • Primary Wearable Sensors for Stroke Patients
  • Robotic Neurorehabilitation & Noninvasive Brain-Machine Interface to Aid Rehabilitation
  • Brain-Machine Interfaces
  • Key Applications of Virtual Reality for Neurological Rehabilitation
  • VR-Centric Gamification in Neurorehabilitation Improves Outcomes for Stroke Patients
  • Technological Advancements in Neuroimaging Techniques Enhance Neurorehabilitation Outcome
  • Advancements in Robotics and Neuroscience Research Give Rise to Next-Generation Rehabilitation Techniques
  • IoT-Powered Rehabilitation Robotics
  • Integration Of Speech Recognition Algorithms
  • Emergence of Novel Multi-electrode Stimulation for Treatment of Spinal Cord Injuries
4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS
UNITED STATES
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
CANADA
JAPAN
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
CHINA
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
EUROPE
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
FRANCE
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION
  • Total Companies Profiled: 95

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • AlterG, Inc.
  • Biometrics Ltd.
  • Bioness Inc.
  • BIONIK Laboratories Corp.
  • Boston Scientific Corporation
  • Ectron Ltd
  • Ekso Bionics Holdings Inc.
  • Eodyne
  • Helius Medical Technologies
  • Hocoma AG
  • Instead Technologies Ltd.
  • Kinestica
  • Medtronic plc
  • Neofect
  • Neuro Rehab VR
  • Reha Technology AG
  • Rehab-Robotics Company Limited.
  • Rex Bionics Ltd
  • Saebo, Inc.
  • Tyromotion GmbH